Literature DB >> 3620353

Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection.

M F Murphy, P Metcalfe, A H Waters, C A Carne, I V Weller, D C Linch, A Smith.   

Abstract

The incidence of lymphopenia, thrombocytopenia and neutropenia was studied in 105 homosexual men with HIV infection. Lymphopenia was common in patients with AIDS (75%), but its incidence in PGL (24%) was not significantly different from that in asymptomatic anti-HIV positive (15%) homosexual men. Neutropenia and thrombocytopenia were found in patients with AIDS or PGL, but not in asymptomatic anti-HIV positive homosexuals. The study suggests that the neutropenia and thrombocytopenia in these patients were due to autoimmune destruction of neutrophils and platelets.

Entities:  

Mesh:

Year:  1987        PMID: 3620353     DOI: 10.1111/j.1365-2141.1987.tb06920.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  41 in total

1.  GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia.

Authors:  M A Nardi; L X Liu; S Karpatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 2.  Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Authors:  Davide Gibellini; Alberto Clò; Silvia Morini; Anna Miserocchi; Cristina Ponti; Maria Carla Re
Journal:  World J Virol       Date:  2013-05-12

3.  Lengthy incubation for homosexual transmission of acquired immunodeficiency syndrome in a 79 year old man.

Authors:  D A Walsh; T C O'Shaughnessy
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

4.  A review of the use of blood and blood products in HIV-infected patients.

Authors:  Karin van den Berg; James van Hasselt; Evan Bloch; Robert Crookes; James Kelley; Jonathan Berger; Charlotte Ingram; Anel Dippenaar; Rajendra Thejpal; Neil Littleton; Tersia Elliz; Gary Reubenson; Mark Cotton; Jennifer C Hull; Pamela Moodley; Yasmin Goga; William Eldridge; Moosa Patel; Eric Hefer; Arthur Bird
Journal:  South Afr J HIV Med       Date:  2012-06-07       Impact factor: 2.744

5.  Hematologic abnormalities associated with simian immunodeficieny virus (SIV) infection mimic those in HIV infection.

Authors:  Amy F Gill; Muhammad H Ahsan; Andrew A Lackner; Ronald S Veazey
Journal:  J Med Primatol       Date:  2012-06       Impact factor: 0.667

6.  The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication.

Authors:  M C Re; G Zauli; G Furlini; S Ranieri; P Monari; E Ramazzotti; M La Placa
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study.

Authors:  Daniel W Gunda; Kahamba G Godfrey; Semvua B Kilonzo; Bonaventura C Mpondo
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

8.  The serology and immunochemistry of HIV-induced platelet-bound immunoglobulin.

Authors:  R J Klaassen; J van der Lelie; A B Vlekke; H M Weigel; J K Eeftinck Schattenkerk; P Reiss; A E von dem Borne
Journal:  Blut       Date:  1989-07

Review 9.  Neutropenia during HIV infection: adverse consequences and remedies.

Authors:  Xin Shi; Matthew D Sims; Michel M Hanna; Ming Xie; Peter G Gulick; Yong-Hui Zheng; Marc D Basson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2014-03-21       Impact factor: 5.311

10.  The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.

Authors:  Hemant Kulkarni; Vincent C Marconi; Weijing He; Michael L Landrum; Jason F Okulicz; Judith Delmar; Dickran Kazandjian; John Castiblanco; Seema S Ahuja; Edwina J Wright; Robin A Weiss; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  Blood       Date:  2009-07-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.